Haoxi Health Technology Limited (HAO)vsMeta Platforms Inc. (META)
HAO
Haoxi Health Technology Limited
$2.87
-2.05%
COMMUNICATION SERVICES · Cap: $1.02M
META
Meta Platforms Inc.
$682.31
-2.43%
COMMUNICATION SERVICES · Cap: $1.65T
Smart Verdict
WallStSmart Research — data-driven comparison
Meta Platforms Inc. generates 534716% more annual revenue ($228.25B vs $42.68M). META leads profitability with a 29.8% profit margin vs -6.5%. META earns a higher WallStSmart Score of 71/100 (B).
HAO
Hold49
out of 100
Grade: D+
META
Strong Buy71
out of 100
Grade: B
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for HAO.
Margin of Safety
+29.4%
Fair Value
$942.34
Current Price
$682.31
$260.03 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Revenue surging 41.2% year-over-year
Earnings expanding 172.7% YoY
Safe zone — low bankruptcy risk
Conservative balance sheet, low leverage
Mega-cap, among the largest globally
Strong operational efficiency at 34.8%
Every $100 of equity generates 26 in profit
Keeps 30 of every $100 in revenue as profit
Growing faster than its price suggests
Revenue surging 28.0% year-over-year
Areas to Watch
Smaller company, higher risk/reward
ROE of -15.5% — below average capital efficiency
Negative free cash flow — burning cash
Currently unprofitable
Weak financial health signals
Earnings declined 13.4%
Comparative Analysis Report
WallStSmart ResearchBull Case : HAO
The strongest argument for HAO centers on Price/Book, Revenue Growth, EPS Growth. Revenue growth of 41.2% demonstrates continued momentum.
Bull Case : META
The strongest argument for META centers on Market Cap, Operating Margin, Return on Equity. Profitability is solid with margins at 29.8% and operating margin at 34.8%. Revenue growth of 28.0% demonstrates continued momentum.
Bear Case : HAO
The primary concerns for HAO are Market Cap, Return on Equity, Free Cash Flow.
Bear Case : META
The primary concerns for META are Piotroski F-Score, EPS Growth.
Key Dynamics to Monitor
HAO profiles as a hypergrowth stock while META is a growth play — different risk/reward profiles.
META carries more volatility with a beta of 1.24 — expect wider price swings.
HAO is growing revenue faster at 41.2% — sustainability is the question.
META generates stronger free cash flow (1.7B), providing more financial flexibility.
Bottom Line
META scores higher overall (71/100 vs 49/100), backed by strong 29.8% margins and 28.0% revenue growth. Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Haoxi Health Technology Limited
COMMUNICATION SERVICES · ADVERTISING AGENCIES · USA
Haoxi Health Technology Limited Class A Ordinary Shares is a pioneering force in the health technology sector, focused on revolutionizing healthcare through innovative, technology-driven solutions. The company harnesses advanced artificial intelligence and data analytics to enhance diagnostic precision, streamline treatment processes, and improve patient management. With a robust commitment to research and development, Haoxi is well-positioned to tackle emerging healthcare challenges, presenting substantial growth opportunities for institutional investors aiming to leverage advancements in this dynamic and rapidly evolving market.
Meta Platforms Inc.
COMMUNICATION SERVICES · INTERNET CONTENT & INFORMATION · USA
Meta Platforms, Inc. develops products that enable people to connect and share with friends and family through mobile devices, PCs, virtual reality headsets, wearables and home devices around the world. The company is headquartered in Menlo Park, California.
Visit Website →Compare with Other ADVERTISING AGENCIES Stocks
Want to dig deeper into these stocks?